APA

Bardiès M., Bardet S., Faivre-Chauvet A., Peltier P., Douillard J. Y., Mahé M., Fiche M., Lisbona A., Giacalone F., Meyer P., Gautherot E., Rouvier E., Barbet J. & Chatal J. F. (19961220). Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chicago

Bardiès M, Bardet S, Faivre-Chauvet A, Peltier P, Douillard J Y, Mahé M, Fiche M, Lisbona A, Giacalone F, Meyer P, Gautherot E, Rouvier E, Barbet J and Chatal J F. 19961220. Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Harvard

Bardiès M., Bardet S., Faivre-Chauvet A., Peltier P., Douillard J. Y., Mahé M., Fiche M., Lisbona A., Giacalone F., Meyer P., Gautherot E., Rouvier E., Barbet J. and Chatal J. F. (19961220). Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MLA

Bardiès M, Bardet S, Faivre-Chauvet A, Peltier P, Douillard J Y, Mahé M, Fiche M, Lisbona A, Giacalone F, Meyer P, Gautherot E, Rouvier E, Barbet J and Chatal J F. Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer. : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 19961220.